Sanofi begins shipping malaria drug made from semisynthetic artemisinin

Sanofi has begun shipping a malaria treatment made via a new manufacturing process that was developed by Amyris and a team of researchers at the University of California, Berkeley, led by American Institute of Chemical Engineers member Jay Keasling. The process can create large amounts of semisynthetic artemisinin in yeast, allowing Sanofi to produce about one third of the global artemisinin supply.

View Full Article in:

FiercePharmaManufacturing · Economist (tiered subscription model), The

Published in Briefs: